Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03072238 |
|---|---|
| Brief Title: | Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer (IPATential150) |
| First Submitted : | March 2, 2017 |
| First Submitted that Met QC Criteria : | March 2, 2017 |
| First Posted : | March 7, 2017 |
| Results First Submitted : | March 15, 2023 |
| Results First Submitted that Met QC Criteria : | March 15, 2023 |
| Results First Posted : | April 10, 2023 |
| Certification/Extension First Submitted : | March 15, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | March 15, 2021 |
| Certification/Extension First Posted : | March 19, 2021 |
| Last Update Submitted that Met QC Criteria : | April 12, 2024 |
| Last Update Posted : | April 16, 2024 |